Betterinvesting™ magazine update on vertex pharmaceuticals inc. and martin marietta materials inc.

Troy, mich. , jan. 10, 2024 /prnewswire/ -- the editorial advisory and securities review committee of betterinvesting magazine today announced vertex pharmaceuticals inc. (nasdaq: vrtx) as its "stock to study" and martin marietta materials inc. (nyse: mlm) as its "undervalued stock" in the march 2024 issue for investors' informational and educational use.
VRTX Ratings Summary
VRTX Quant Ranking